Video

Federal Compounding Law and Health-System Pharmacists

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.

Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.

This video was taken at ASHP's Summer Meetings and Exposition in June 2015.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
PCV10 Elicits Durable Immune Response in T2D, Though Response Remains Inferior to Non-Diabetics
April 19th 2025

PCV10 Elicits Durable Immune Response in T2D, Though Response Remains Inferior to Non-Diabetics

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond
April 18th 2025

A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond

Sanam Kolia, PharmD, RPh
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
People scratch the itch with hand, Elbow, itching, Healthcare And Medicine, Men with skin problem concept
Published: April 18th 2025 | Updated: April 18th 2025

FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria

Luke Halpern, Assistant Editor
Allergic asthma airways -- Image credit: Thipphaphone | stock.adobe.com
April 18th 2025

Alternative Methods in Identifying Allergic, Nonallergic Type 2 Asthma Endotypes Are Necessary

Gillian McGovern, Associate Editor